Expired activity
Please go to the PowerPak
homepage and select a course.
PCSK9 Inhibitors: A Little Extra Work With a Big Reward
This educational activity is sponsored by Postgraduate Healthcare Education, LLC (PHE) and Spire Learning.
This activity is supported by educational funding donation provided by Amgen.
FACULTY
Sarah A. Nisly, PharmD, BCPS, FCCP
Associate Professor of Pharmacy
Wingate University School of Pharmacy
Wingate, NC
Clinical Pharmacy Specialist, Internal Medicine
Wake Forest Baptist Medical Center
Winston-Salem, NC
FINANCIAL DISCLOSURE
Sarah A. Nisly, PharmD, BCPS, FCCP, has no relevant affiliations or financial relationships with a commercial interest to disclose.
The following reviewer, Barry E. Bleske, PharmD, FCCP, hereby states she has no relevant affiliation or financial relationship or relationship to products or devices with a commercial interest related to the content of this activity to disclose.
Susanne Batesko, RN, BSN, Robin Carrino, Aisha Cobbs, PhD, Molly Vrana, as well as the planners, managers, and other individuals, not previously disclosed, who are in a position to control the content of Spire Learning/Postgraduate Healthcare Education (PHE) continuing education (CE) activities hereby state that they have no relevant conflicts of interest and no financial relationships or relationships to products or devices during the past 12 months to disclose in relation to this activity. We are committed to providing participants with a quality learning experience and to improve clinical outcomes without promoting the financial interests of a proprietary business.
ACCREDITATION STATEMENTS
PHARMACY
Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
UAN: 0430-0000-17-093-H01-P
Credits: 0.5 hour (0.05 ceu)
Published: November 20, 2017
Expires: November 30, 2018
Type of Activity: Knowledge
Media: Internet
Fee Information: There is no fee for this educational activity.
Estimated time to complete activity: 30 minutes
TARGET AUDIENCE
Pharmacists with an interest in the management of hypercholesterolemia.
HOW TO EARN CREDIT
During the period November 20, 2017 through November 30, 2018, participants must 1) read the learning objectives and faculty disclosures; 2) view the educational activity; and 3) complete the post-test and evaluation form directly after the activity within a maximum of 60 days of participating in the activity. To answer the questions, click on your selected choice for each answer then proceed to the next question. Once completed, click on the Grade Exam button at the bottom of the page. Your credit will be automatically uploaded to CPE Monitor.
GOAL
To describe the pharmacist's role in obtaining prior authorizations and renewals. This article will also discuss how to overcome barriers to optimal adherence in patients receiving PCSK9 inhibitors.
EDUCATIONAL OBJECTIVES
Upon completion of this activity, participants should be better able to:
- Describe the process for obtaining prior approval for PCSK9 inhibitors.
- Implement communication and educational strategies to address common barriers that contribute to suboptimal adherence to PCSK9 inhibitor therapy.
REQUIRED COMPUTER HARDWARE/SOFTWARE
Please ensure the computer system you plan to use meets the following minimum requirements:
- Operating System: Windows 98 or higher & Macintosh 2.2 or higher
- Internet Browser (Mac &/ Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher
- Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
- Peripherals: Computer speakers or headphones
- Monitor Screen Resolution: 320 x 480 or higher
- Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, Flash Player & HTML5
Disclosure of Unlabeled Use and Disclaimer
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Postgraduate Healthcare Education, LLC, Spire Learning, and Amgen. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions, and possible contraindications on dangers in use, (review of any applicable manufacturer's product information) and comparison with recommendations of other authorities.
The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc) is subject to constant change, the reader is advised to check the manufacturer's package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration (FDA). Neither the publisher nor sponsor promotes the use of any agent outside of approved labeling. Statements made in this monograph have not been evaluated by the FDA. Nutritional products discussed are not intended for the diagnosis, treatment, cure, or prevention of any disease.
